To begin with, Bitterli et al. demonstrated that the levels of cEPCs (CD34+ KDR+) were lower in PAD patients in comparison with HC, and the colony-forming ability of these cells was also reduced in the disease group. This evidence concerns the gene CD34 and peripheral arterial disease.